Facebook
Instagram
Linkedin
Pinterest
Reddit
Twitter
Sign in
Click here - to use the wp menu builder
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
PRIVACY STATEMENT MEDICAL DEVICE NEWS MAGAZINE
Password recovery
Recover your password
your email
Search
Home
Tags
Bracco Diagnostics
Bracco Diagnostics
ProHance (Gadoteridol) Injection, 279.3 mg/mL, For Pediatric Patients Younger Than Two Years Receives FDA Approval
December 23, 2020
ProHance was previously approved for this use in patient populations over the age of two.
By using this website you agree to accept Medical Device News Magazine
Privacy Policy
Accept